Balanced Scorecard -
Managing Alliances with the Balanced Scorecard - Sun and Planets Spirituality AYINRIN
From The Palace Of Kabiesi Ebo Afin!Ebo Afin Kabiesi! His Magnificence Oloja Elejio Oba Olofin Pele Joshua Obasa De Medici Osangangan broad-daylight natural blood line 100% Royalty The God, LLB Hons, BL, Warlord, Bonafide King of Ile Ife kingdom and Bonafide King of Ijero Kingdom, Number 1 Sun worshiper in the Whole World.I'm His Magnificence the Crown.
For Spiritual Consultations, Spiritual divination reading, Guidance and Counseling, spiritual products and spiritual Services, offering of Spiritual Declarations , call or text Palace and Temple Phone and Whatsapp contact: +2348166343145, Phone And WhatsApp Contact : +2347019686274 ,Mail: obanifa87@gmail.com, Facebook page: Sun Spirituality.Website:www.sunspirituality.com.
Our Sun spiritual Temple deliver Spiritual Services to Companies owners, CEOs, Business brands owners, Bankers, Technologists, Monarchs, Military officers, Entrepreneurs, Top Hierarchy State Politicians, and any Public figures across the planet.
Author:His Magnificence the Crown, Kabiesi Ebo Afin! Oloja Elejio Oba Olofin Pele Joshua Obasa De Medici Osangangan Broadaylight.
Corporate
alliances are a 50/50 bet—at least according to a recent study by
McKinsey & Company, which found that only half of all joint ventures
yield returns to each partner above the cost of capital. That’s
worrying, given that partnerships and alliances are central to many
companies’ business models. Originally used to outsource noncore parts
of supply chains, alliances today are expected to generate a competitive
advantage. So it is necessary to dramatically improve their odds of
success.
Why
do alliances fail so often? The prime culprit is the way they are
traditionally organized and managed. Most alliances are defined by
service level agreements (SLAs) that identify what each side commits to
delivering rather than what each hopes to gain from the partnership. The
SLAs emphasize operational performance metrics rather than strategic
objectives, and all too often those metrics become outdated as the
business environment changes. Alliance managers don’t know whether to
stick to the original conditions or renegotiate. By that time, the
companies’ leaders have returned to run their own organizations and
haven’t followed up to ensure that their vision for synergies is being
realized. The middle managers coordinating the alliance, who have no
clear way to translate their leaders’ vision into action, simply focus
on achieving the operational SLA targets instead of working across
organizational boundaries to make the alliance a strategic success. And
because the managers usually remain under the HR policies and follow the
career development paths of their parent organization, they have little
incentive to commit much energy to the project.
With
this dynamic in place, it’s easy to see why most alliances deliver
disappointing performance. But the problems can be remedied if companies
switch their focus from operations and contractual obligations to
strategy and commitment. In the following pages we show how the balanced
scorecard (BSC) management system helps companies create better
alignment with their alliance partners. Drawing on the experience of two
strategic partners, Solvay Pharmaceuticals and Quintiles, we
demonstrate how applications of BSC techniques can clarify strategy,
drive behavioral change, and provide a governance system for strategy
execution.
Anatomy of a Strategic Alliance
Solvay,
a top-40 pharmaceutical company, develops leading neuroscience,
cardio-metabolic, influenza vaccine, and pancreatic enzyme products.
Headquartered in Brussels, it employs 10,000 people worldwide.
A
research-driven organization, Solvay has formidable competencies in the
drug discovery process. But the average cost of bringing new drugs to
market has escalated to more than $1 billion per successful compound,
making it harder for Solvay to capitalize on its research skills.
Clinical trials require access to patients, physicians, and health care
organizations, areas where Solvay has less of an advantage.
Historically, it had selected clinical trials suppliers through a
competitive bidding process for each new compound. In 2000, Solvay’s
R&D unit worked with 50 different suppliers. It’s no wonder
executives believed that Solvay could be more efficient and achieve
better results if it could outsource the management of all clinical
trial work to a single partner.
Solvay
began the transition to this model by choosing Quintiles, one of its
existing suppliers, to perform all stages of the trial process. Based in
North Carolina and employing 23,000 people in more than 50 countries,
Quintiles has helped develop or commercialize all of the 30 best-selling
pharmaceutical products and nine of the top 10 biologics (medical
products created by biological processes). In 2001 the two companies
moved from a transactional relationship to a preferred partnership.
Under the terms of the agreement, Solvay consolidated a significant
number of its outsourced projects under Quintiles in return for
reductions in Quintiles’s normal prices. The two companies formed a
joint clinical team for each compound in order to manage strategic and
operational aspects of conducting clinical trials. They also formed
functional teams, staffed by employees from both firms, to improve the
major processes in the drug development cycle, such as procurement of
clinical supplies and alignment of finance and human resources
practices. A joint development committee provided oversight, set
milestones, and monitored progress.
The
initial five-year contract worked well. But when it came up for renewal
in 2006, both companies thought that they could generate even more
value if they could upgrade their partnership to a true alliance. An
integrated development platform—leveraging each company’s respective
strengths—would provide opportunities for gains in productivity,
efficiency, and development speed above and beyond traditional
outsourcing. Both parties were also willing to share development costs
for certain Solvay products, thus increasing Solvay’s development
capacity and sending more work to Quintiles, which generated more
opportunities for milestone payments, should successful outcomes be
achieved.
The
alliance’s proponents had to overcome concerns within Solvay about loss
of control as more of its in-house activities got outsourced. Senior
executives of the two companies had to endorse and commit to the
alliance strategy, which included sharing profits and risks. The
companies knew they would have to change the way they worked together.
Armed with knowledge gathered from the McKinsey study and others about
the likely shortfalls in alliance outcomes, executives identified the
following problems that had to be overcome:
- focusing more on the contractual terms of the alliance than on a joint strategy;
- spending more time and effort selling the alliance internally than managing its strategy;
- concentrating more on controlling the alliance and extracting returns than on removing barriers to the successful execution of the strategy.
The
executives believed that a management system based on the tools of the
balanced scorecard, which both companies already used internally, would
help address those issues. From past experience with the system, both
sides felt that jointly drawing up a balanced scorecard and a strategy
map would promote consensus on and alignment with the goals of the
alliance. The scorecard and strategy map would also serve as a framework
for a governance system to monitor progress toward goals and create
incentives for both parties to achieve them.
Building the Alliance Scorecard
A
seven-person joint steering committee (JSC) oversaw the creation of the
map and scorecard and, subsequently, led the governance process.
Chaired by Solvay’s head of R&D, the committee included Solvay’s
head of clinical research, its CFO, the president of Quintiles’s
clinical development group, and its executive vice president of
corporate development. Two “alliance managers,” one from each company
but agreed on by both, rounded out the team. The alliance managers were
responsible for driving the implementation of the strategic objectives
set by the JSC. They oversaw projects, developed management structures,
implemented performance management tools, and served as the primary
communication contacts for alliance participants.
The
JSC appointed a project team consisting of the two alliance managers
and employees from both organizations’ strategic planning, project
management, and corporate communications departments. An external
consultant provided an objective perspective and helped negotiate
agreement on joint goals. Team members conducted one-on-one interviews
with key executives, asking questions such as, “How can we create
shareholder value for both companies?,” “How do we create
differentiation in the marketplace?,” and “What issues and current
problem areas should we address?” The discussions uncovered some
negative aspects of the companies’ five-year partnership. The Quintiles
alliance manager observed, “There are still pockets of people not
working strategically within the alliance. We need to help them
understand that this alliance is different from a traditional,
transaction-driven, customer-vendor model.”
After
a series of workshops and interviews with each JSC member, the project
team identified the alliance’s strategic objectives. Following BSC
practice, it sorted those objectives into five strategic themes:
Living the alliance:
Ensure
that we have the right culture (including trust), communication,
leadership, people development, IT, and rewards and recognition.
Collaboration:
Create the transparency we desire and make the best use of resources and services across organizations and third parties.
Speed and process innovation:
Do
things right; leverage our global expertise; and improve the start-up
and management of studies to achieve breakthrough results.
Growth:
Create
the right portfolio of new products; collaborate on decisions to
develop compounds; improve investment management; and accelerate the
flow of compounds into the clinical development phase.
Value for both:
Create value for both organizations by jointly driving all these activities.
The
project team next worked with the JSC and the employees who would be
involved in the alliance to draw a complete strategy map that showed how
the objectives embedded in these various themes would collectively
deliver value. In the exhibit “The Alliance Strategy Map,” the map is
broken down into four areas (or perspectives, in BSC parlance) that show
how the objectives for the employees and organizations feed into the
objectives for business processes, which satisfy the needs of the
alliance’s customers. Fulfilling customer expectations, in turn, creates
value for the alliance’s stakeholders. These four perspectives
correspond closely to those on a conventional map or scorecard, except
here, the stakeholder perspective replaces the financial one.
The Alliance Strategy Map
Three
of the themes contain strategic objectives that cross multiple BSC
perspectives. The speed and process innovation theme, for example,
includes objectives in the business-process, customer, and stakeholder
perspectives. Two themes exist in only one of the four perspectives. To
further clarify joint expectations, the project team placed the expected
“wins” for each company next to each objective. These served as helpful
reference points when the companies negotiated targets.
The
process of reaching consensus on the themes, the objectives within each
theme, and the overall strategy map created buy-in and understanding
among all participants. Alliance employees engaged in candid dialogue
during joint working sessions about the potential benefits for each
company. Having such frank conversations was the first step toward
achieving greater transparency and establishing trust.
Next,
the functional teams (which already existed under the preferred
partnership arrangement) put together scorecards for the five themes,
specifying metrics, targets, and initiatives for each objective. (The
scorecard for one theme is shown in the exhibit “The Collaboration Theme
Scorecard.”) With the complete map and the five theme scorecards in
hand, the alliance managers could then determine the personal objectives
of and rewards for each of the more than 500 employees involved in the
alliance. Each company, of course, had its own incentive and reward
system. But now the performance metrics for employees in the alliance
were aligned with those identified in the map and scorecards.
The Collaboration Theme Scorecard
The
functional teams used the map and scorecards to identify best practices
and to redesign key business processes. All the joint clinical teams
then implemented the improved processes in the trials for their
compounds.
Finally,
the alliance managers, with help from both companies’ internal
communications departments, led a major push to promote the message to
alliance employees. Ambassadors used such tools as laminated strategy
maps, video presentations by company executives and alliance leaders,
and even an alliance game to make sure all stakeholders understood the
mission and the goals of the partnership. The ambassadors followed up
with periodic newsletters and e-mails touting progress made on the five
strategic themes.
Establishing the Governance Structure
Although
drawing up the map and scorecard got the two companies and alliance
employees on the same page, participants recognized that they needed a
governance process to continually monitor the partnership and to keep it
on track. The alliance managers asked five senior executives to become
“theme leaders”; each would be accountable for one theme’s objectives
and would oversee related cross-functional initiatives.
The
executives were supported by theme teams, employees who worked to
ensure that the functional and joint clinical teams contributed to the
theme’s cross-functional objectives. For example, the speed and process
innovation team held regular meetings to stimulate ideas on improving
and accelerating clinical trials and to share those suggestions with the
functional and joint clinical teams. The theme teams also solicited
suggestions from the functional and joint clinical teams on ways to
achieve the theme’s strategic objectives. Theme team members presented
the most promising initiatives to the joint steering committee. When
proposals were approved, the theme teams then monitored their execution
by the functional and joint clinical teams.
The
Solvay-Quintiles joint steering committee meets quarterly to discuss
the alliance’s progress. With input from the theme, functional, and
joint clinical teams, the JSC monitors achievements, addresses emerging
relationship issues, reallocates resources, and makes decisions on any
unresolved issues. It serves, in effect, as a court of final appeal over
disagreements about what projects should or should not be carried out
by the alliance.
The
theme team meetings and JSC reviews help the two companies resolve
problems that, if left unchecked, would undermine the collaboration
required by the alliance. For instance, the theme teams realized that
security systems and firewalls blocked employees of one company from
accessing information stored inside the other. Because all sides had
agreed that information sharing was a strategic priority, the JSC felt
empowered to work with the IT functions in each company to overcome
their resistance to giving alliance employees access to Quintiles’s
operational dashboards. Now members of the alliance can easily monitor
the progress of clinical trials.
The Payoff
The
new approach has yielded impressive results. The alliance reduced total
cycle time for clinical studies by approximately 40%, an achievement
that brings new products to market much faster and leads to tremendous
cost reductions. Three global registration programs were completed from
2003 to 2007, a much faster rate than the companies had previously
achieved. In addition, one functional team developed a new way to manage
nonperforming sites (those recruiting inadequate numbers of patients).
That led to the alliance halving the number of nonperforming sites and
saving €25,000 to €35,000 per site (a study can have 20 to 150 sites).
Moreover, the teams felt that the shared understanding of joint
objectives on the strategy map empowered them to make strategic and
scientific decisions much earlier in a clinical program’s design—saving
time and money and, more important, keeping everyone’s focus on
delivering the alliance strategy.
Members
of the joint steering committee acknowledge that building the alliance
strategy map and theme scorecards required more time than any map or
scorecard built within their own companies. The process required
aligning two organizations with entirely different business models and
cultures—one is a research-driven pharmaceutical company, the other an
operationally oriented services company. Yet the JSC is so pleased with
the benefits of the new management system that it is replicating the
process with several key customer groups, medical specialists in the
world’s leading academic medical centers, and payer organizations.
We’ve
described in detail the Solvay-Quintiles experience of using balanced
scorecard techniques to create alliance value. But this experience is
not unique. Infosys, the Indian IT services provider, has built more
than two dozen “relationship scorecards” with customers and uses these
in quarterly meetings with executives in its client organizations (see
A. Martinez, “Infosys’s Relationship Scorecard: Transformational
Partnerships,” HBS Case 109-006). LagasseSweet, a $1 billion wholesaler
in the building services industry, also collaborates with its leading
trading partners—manufacturers and distributors—to produce scorecards to
measure performance. As a result it has saved millions of dollars and
improved responsiveness, service, and availability up and down the
supply chain. What’s more, it has identified $150 million in new revenue
opportunities.
For
cross-entity collaboration to yield the highest rewards, the partners
must first agree on strategy and then design metrics to determine how
well the strategy is being implemented. They must communicate a common
vision and offer incentives that motivate employees to improve
collaboration and deliver results. They also need a process that allows
them to talk candidly about difficulties, resolve disputes, share
information, and continually adapt the strategy to evolving external
conditions as well as to newly created internal capabilities. The
balanced scorecard management system provides a framework for partners
to work collaboratively and productively to achieve benefits that
neither could accomplish on its own.
Was this article helpful? Connect with me.
Follow The SUN (AYINRIN), Follow the light. Be bless. I am His Magnificence, The Crown, Kabiesi Ebo Afin!Ebo Afin Kabiesi! His Magnificence Oloja Elejio Oba Olofin Pele Joshua Obasa De Medici Osangangan broad-daylight natural blood line 100% Royalty The God, LLB Hons, BL, Warlord, Bonafide King of Ile Ife kingdom and Bonafide King of Ijero Kingdom, Number 1 Sun worshiper in the Whole World.I'm His Magnificence the Crown. Follow the light.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.